Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jules Deforges

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Iscience|October 20, 2023
<i>In vitro</i> vascularized immunocompetent patient-derived model to test cancer therapiesHélène Lê, Jules Deforges, Guoqiang Hua, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8<sup>+</sup> T cell immunity to reject 'cold' tumorsMonika Semmrich, Jean-Baptiste Marchand, Laetitia Fend, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Iscience|October 20, 2023
<i>In vitro</i> vascularized immunocompetent patient-derived model to test cancer therapiesHélène Lê, Jules Deforges, Guoqiang Hua, et al.
Journal for Immunotherapy of Cancer|January 21, 2022
Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8<sup>+</sup> T cell immunity to reject 'cold' tumorsMonika Semmrich, Jean-Baptiste Marchand, Laetitia Fend, et al.
Pageof 3